Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Rogler, G."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Caparrós E, Wiest R, Scharl M, Rogler G, Gutiérrez Casbas A, Yilmaz B, Wawrzyniak M, Francés R
Publikováno v:
Gut Microbes
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Crohn's disease (CD) is a major form of inflammatory bowel disease characterized by transmural inflammation along the alimentary tract. Changes in the microbial composition and reduction in species diversity are recognized as pivotal hallmarks in dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3eb77cc80a8ad2a15546e086dca97dca
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7353
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7353
Autor:
Gionchetti, P, Dignass, A, Danese, S, Dias, FJM, Rogler, G, Lakatos, PL, Adamina, M, Ardizzone, S, Buskens, CJ, Sebastian, S, Laureti, S, Sampietro, GM, Vucelic, B, van der Woude, C.J., Barreiro-de Acosta, M, Maaser, C, Portela, F, Vavricka, S R, Gomollon, F, Ecco
Publikováno v:
Journal of Crohn's and Colitis, 11(2), 135-149. Oxford University Press
Brynskov, J & ECCO 2017, ' 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016 : Part 2: Surgical management and special situations ', Journal of Crohn's and Colitis, vol. 11, no. 2, pp. 135-149 . https://doi.org/10.1093/ecco-jcc/jjw169
Journal of Crohn s & colitis, 11(2), 135-149. Elsevier
Brynskov, J & ECCO 2017, ' 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016 : Part 2: Surgical management and special situations ', Journal of Crohn's and Colitis, vol. 11, no. 2, pp. 135-149 . https://doi.org/10.1093/ecco-jcc/jjw169
Journal of Crohn s & colitis, 11(2), 135-149. Elsevier
This paper is the second in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s disease [CD] and concerns the surgical management of CD
Autor:
Lang, B M, Biedermann, L, van Haaften, W T, de Vallière, C, Schuurmans, M, Begré, S, Zeitz, J, Scharl, M, Turina, M, Greuter, T, Schreiner, P, Heinrich, H, Kuntzen, T, Vavricka, S R, Rogler, G, Beerenwinkel, N, Misselwitz, B, Swiss IBD Cohort Study Group
Publikováno v:
Alimentary Pharmacology & Therapeutics, Vol. 47, No 1 (2018) pp. 55-66
Alimentary Pharmacology & Therapeutics, 47(1), 55-66. Wiley
Alimentary Pharmacology & Therapeutics, 47(1), 55-66. Wiley
Background: Smoking is a strong environmental factor leading to adverse outcomes in Crohn's disease, but a more benign course in ulcerative colitis. Several single nucleotide polymorphisms (SNPs) are associated with smoking quantity and behaviour.Aim
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vavricka, St. R.1 stephan.vavricka@usz.ch, Rogler, G.1
Publikováno v:
Praxis (16618157). 1/21/2009, Vol. 98 Issue 2, p77-81. 5p.
Autor:
Safroneeva E, Vavricka S R, Fournier N, Pittet V, Peyrin-Biroulet L, Straumann A, Rogler G, Schoepfer A M, Swiss IBD Cohort Study Group
Publikováno v:
Alimentary pharmacology & therapeutics
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2015, 42 (8), pp.977-989. ⟨10.1111/apt.13363⟩
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2015, 42 (8), pp.977-989. ⟨10.1111/apt.13363⟩
BACKGROUND The impact of early treatment with immunomodulators (IM) and/or TNF antagonists on bowel damage in Crohn's disease (CD) patients is unknown. AIM To assess whether 'early treatment' with IM and/or TNF antagonists, defined as treatment withi
Autor:
Rieder, F., Bettenworth, D., Ma, C., Parker, C. E., Williamson, L. A., Nelson, S. A., van Assche, G., Di Sabatino, A., Bouhnik, Y., Stidham, R. W., Dignass, A., Rogler, G., Taylor, S. A., Stoker, J., Rimola, J., Baker, M. E., Fletcher, J. G., Panes, J., Sandborn, W. J., Feagan, B. G.
Publikováno v:
Alimentary Pharmacology & Therapeutics; Aug2018, Vol. 48 Issue 3, p347-357, 11p, 1 Diagram, 1 Chart
Autor:
Lang, B. M., Biedermann, L., van Haaften, W. T., de Vallière, C., Schuurmans, M., Begré, S., Zeitz, J., Scharl, M., Turina, M., Greuter, T., Schreiner, P., Heinrich, H., Kuntzen, T., Vavricka, S. R., Rogler, G., Beerenwinkel, N., Misselwitz, B., the Swiss IBD Cohort Study Group
Publikováno v:
Alimentary Pharmacology & Therapeutics; Jan2018, Vol. 47 Issue 1, p55-66, 12p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.